Liquidia Corporation reports results for the quarter ended June 30 - Earnings Summary
Liquidia Corporation reports results for the quarter ended June 30 - Earnings Summary
Liquidia Corporation LQDA.OQ reported quarterly adjusted earnings of 74 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -49 cents. The mean expectation of eight analysts for the quarter was for earnings of 74 cents per share. Wall Street expected results to range from 56 cents to 97 cents per share.
Revenue rose 1,828.1% to $170.38 million from a year ago; analysts expected $168.54 million.
Liquidia Corporation's reported EPS for the quarter was 74 cents.
The company reported quarterly net income of $74.72 million.
Liquidia Corporation shares had risen by 10.4% this quarter and gained 155.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 2.5% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for Liquidia Corporation is $76.88, about 14.5% below its last closing price of $88.05
This summary was machine generated from LSEG data August 12 at 01:30 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.74 | 0.74 | Met |
Mar. 31 2026 | 0.41 | 0.52 | Beat |
Dec. 31 2025 | 0.18 | 0.17 | Missed |
Sep. 30 2025 | -0.40 | -0.04 | Beat |
Recent news on Liquidia
See all newsUS STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing